PharmaLex Belgium SA

47.1 FTE

PharmaLex Belgium reported revenue of €8.37m for the 2024 financial year (annual accounts filed with the NBB on 19 Aug 2026), with 47.1 full-time equivalents.

By total assets for 2024, PharmaLex Belgium ranks among the 5,000 largest of the 47,119 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0667.829.063 · VAT BE0667829063
1930 Zaventem
active in Business and other management consultancy activities (NACE 70200)
operating since 19 Dec 2016 (≈ 10 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of PharmaLex Belgium shows with a free account.

See the score
Profile
SA Small · 47.1 FTE since 2016
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2024

Revenue€8.37m
Net result−102,323 €
Equity€2.36m
Cash€1.07m
EBITDA513,347 €
Total assets€4.97m
Headcount (avg FTE)47.1
The line marks its sector median: 58.4% (26338 companies).

Change 2021 → 2024: Revenue +81 % Equity +155 % Total assets +89 % Headcount (avg FTE) +84 %

Accounts of the company itself (not consolidated).

The full file covers 8 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

PharmaLex Belgium's annual accounts

20242023202220212020
Revenue€8.37m
Net result−102,323 €
Equity€2.36m
Cash€1.07m
EBITDA513,347 €
Total assets€4.97m

Filed annual accounts

  • Year ended 30 Sep 2024filed on 19 Aug 2026
  • Year ended 30 Sep 2023filed on 23 Jul 2024
  • Year ended 31 Dec 2022filed on 24 Jul 2023
  • Year ended 31 Dec 2021filed on 29 Jul 2022
  • Year ended 31 Dec 2020filed on 23 Jul 2021

PharmaLex Belgium's financial analysis

Management and control of PharmaLex Belgium

5 active director(s) in the register.

PharmaLex Belgium's shareholders and holdings →

PharmaLex Belgium's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0667.829.063
VAT number
BE0667829063
Peppol
Registered · 0208:0667829063 · as of 10 Nov 2026
Legal form
SA
Incorporated
19 Dec 2016
Registered office
1930 Zaventem
Size
Small · 47.1 FTE
Latest accounts
2024 · filed on 19 Aug 2026
Activity
Business and other management consultancy activities (NACE 70200)

PharmaLex Belgium (SA) has been based in Zaventem since 2016, active in: business and other management consultancy activities. For 2024, it reports revenue of €8.37m, a net loss of 102,323 € and equity of €2.36m. With 47.1 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 47.4%, below the median of its sector (58.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to PharmaLex Belgium

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about PharmaLex Belgium

What is the revenue of PharmaLex Belgium?

According to the 2024 annual accounts filed with the NBB, the revenue of PharmaLex Belgium amounts to 8,370,817 €.

What is the VAT number of PharmaLex Belgium?

In Belgium, the VAT number is the company number prefixed with BE: BE0667829063 for PharmaLex Belgium, if the company is VAT-registered. Its company number (CBE) is 0667.829.063.

Where is the registered office of PharmaLex Belgium?

According to the CBE register, the registered office of PharmaLex Belgium is in 1930 Zaventem.

What is the equity of PharmaLex Belgium?

At the close of the 2024 financial year, the equity of PharmaLex Belgium amounts to 2,359,097 €, a solvency of 47.4% of total assets.

How many people work at PharmaLex Belgium?

47.1 full-time equivalents on average according to the 2024 social balance sheet.

Who manages PharmaLex Belgium?

The register lists 5 active mandates at PharmaLex Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is PharmaLex Belgium within its sector?

By total assets for 2024, PharmaLex Belgium ranks among the 5,000 largest of the 47,119 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.

Idonis

The full file of PharmaLex Belgium

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 30 Sep 2026

No credit card, no commitment.

What each plan unlocks →